Samsara BioCapital
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
7Deep-tech portfolio6 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Enlaza Therapeutics
34Co-investorsShare a portfolio company
Portfolio · 7 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Enlaza Therapeutics | Biotech | Active | Sep 11, 2025 | $103.0M |
| A2 Biotherapeutics | Biotech | Active | Dec 16, 2022 | $118.9M |
| Jade Biosciences | Biotech | Active | — | — |
| Ottimo Pharma | Biotech | Active | — | — |
| Parabilis Medicines | Biotech | Active | — | — |
| Sidewinder Therapeutics | Biotech | Active | — | — |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
Peer ranks
Portfolio size#60
Portfolio exits#160
Raises, 12 months#88
Co-investors#53
Co-investors
- Frazier Healthcare PartnersVenture capital3 shared
- Foresite CapitalVenture capital2 shared
- MedicxiVenture capital2 shared
- Amgen VenturesVenture capital1 shared
- Andreessen HorowitzVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Asahi Kasei Corporate Venture CapitalVenture capital1 shared
- Avalon VenturesVenture capital1 shared
- Avoro Capital AdvisorsVenture capital1 shared
- Blackstone Life SciencesVenture capital1 shared
Sectors
- Biotech7
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.